[HTML] nature.com

[HTML][HTML] Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication

X Pang, Y Cui, Y Zhu - Acta Pharmacologica Sinica, 2020 - nature.com
Dear Editor, Since December 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a pneumonia outbreak in Wuhan city, China, followed by global …
被引用次数：61 相关文章

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.

X Pang, Y Cui, Y Zhu - Acta Pharmacologica Sinica, 2020 - europepmc.org
Dear Editor, Since December 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a pneumonia outbreak in Wuhan city, China, followed by global …

[引用][C] Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication

X Pang, Y Cui, Y Zhu - Acta pharmacologica Sinica, 2020 - pubmed.ncbi.nlm.nih.gov
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its
complication Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and …
[HTML] nih.gov

[HTML][HTML] Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication

X Pang, Y Cui, Y Zhu - Acta Pharmacologica Sinica, 2020 - ncbi.nlm.nih.gov
Dear Editor, Since December 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a pneumonia outbreak in Wuhan city, China, followed by global …

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.

X Pang, Y Cui, Y Zhu - Acta Pharmacologica Sinica, 2020 - europepmc.org
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused a pneumonia outbreak in Wuhan city, China, followed by global spread [1, 2]. As of 9 …